$GBTG
Global Business Travel Group, Inc.

2024 Q2 Form 10-Q Financial Statement

#000182087224000024 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $625.0M $610.0M $549.0M
YoY Change 5.57% 5.54% 4.17%
Cost Of Revenue $238.0M
YoY Change -2.06%
Gross Profit $311.0M
YoY Change 9.51%
Gross Profit Margin 56.65%
Selling, General & Admin $179.0M $185.0M $259.0M
YoY Change -5.79% 3.35% -4.78%
% of Gross Profit 83.28%
Research & Development $112.0M $108.0M
YoY Change 9.8% 10.2%
% of Gross Profit
Depreciation & Amortization $47.00M $49.00M
YoY Change 2.17% 2.08%
% of Gross Profit 15.76%
Operating Expenses $583.0M $594.0M $308.0M
YoY Change -1.19% 1.19% -3.75%
Operating Profit $42.00M $16.00M $3.000M
YoY Change 2000.0% -277.78% -108.33%
Interest Expense $33.00M -$46.00M
YoY Change -2.94% -9.8%
% of Operating Profit 206.25% -1533.33%
Other Income/Expense, Net -$1.000M $7.000M $0.00
YoY Change -80.0% 40.0% -100.0%
Pretax Income $1.000M $8.000M -$43.00M
YoY Change -101.75% -122.86% -49.41%
Income Tax -$26.00M $27.00M $3.000M
% Of Pretax Income -2600.0% 337.5%
Net Earnings $27.00M -$19.00M -$47.00M
YoY Change -149.09% -29.63% 80.77%
Net Earnings / Revenue 4.32% -3.11% -8.56%
Basic Earnings Per Share $0.06 -$0.04
Diluted Earnings Per Share $0.06 -$0.04 -$0.10
COMMON SHARES
Basic Shares Outstanding 472.6M shares 472.6M shares 467.0M shares
Diluted Shares Outstanding 470.7M shares 461.4M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $476.0M
YoY Change 57.1%
Cash & Equivalents $515.0M $475.0M $476.0M
Short-Term Investments
Other Short-Term Assets $94.00M
YoY Change -27.69%
Inventory
Prepaid Expenses
Receivables $712.0M $812.0M $726.0M
Other Receivables $50.00M $37.00M $42.00M
Total Short-Term Assets $1.448B $1.476B $1.360B
YoY Change -2.62% 1.79% 10.21%
LONG-TERM ASSETS
Property, Plant & Equipment $231.0M $232.0M $282.0M
YoY Change 1.32% 1.75% 2.17%
Goodwill $1.207B $1.206B $1.212B
YoY Change 0.0% 0.67% 2.02%
Intangibles $505.0M $528.0M $552.0M
YoY Change -15.41% -14.29% -13.21%
Long-Term Investments $13.00M $13.00M $14.00M
YoY Change 0.0% -7.14% 0.0%
Other Assets $61.00M $64.00M $50.00M
YoY Change 7.02% 45.45% -86.84%
Total Long-Term Assets $2.334B $2.359B $2.391B
YoY Change -6.38% -5.6% -4.13%
TOTAL ASSETS
Total Short-Term Assets $1.448B $1.476B $1.360B
Total Long-Term Assets $2.334B $2.359B $2.391B
Total Assets $3.782B $3.835B $3.751B
YoY Change -4.97% -2.89% 0.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $333.0M $386.0M $302.0M
YoY Change -13.73% 10.29% 19.37%
Accrued Expenses $391.0M
YoY Change -16.63%
Deferred Revenue $18.00M $30.00M $19.00M
YoY Change -33.33% 7.14% 0.0%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $7.000M $8.000M $7.000M
YoY Change 16.67% 100.0% 133.33%
Total Short-Term Liabilities $879.0M $982.0M $831.0M
YoY Change -3.19% 11.34% 7.5%
LONG-TERM LIABILITIES
Long-Term Debt $1.358B $1.355B $1.355B
YoY Change 0.37% 0.3% 11.16%
Other Long-Term Liabilities $33.00M $28.00M $33.00M
YoY Change -35.29% -44.0% -90.32%
Total Long-Term Liabilities $1.391B $1.383B $1.388B
YoY Change -0.93% -1.28% -11.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $879.0M $982.0M $831.0M
Total Long-Term Liabilities $1.391B $1.383B $1.388B
Total Liabilities $2.564B $2.661B $2.539B
YoY Change -2.92% 2.46% -29.0%
SHAREHOLDERS EQUITY
Retained Earnings -$1.430B -$1.456B -$1.437B
YoY Change 648.69% 722.6% 721.14%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares
Shareholders Equity $1.214B $1.171B $1.208B
YoY Change
Total Liabilities & Shareholders Equity $3.782B $3.835B $3.751B
YoY Change -4.97% -2.89% 0.62%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $27.00M -$19.00M -$47.00M
YoY Change -149.09% -29.63% 80.77%
Depreciation, Depletion And Amortization $47.00M $49.00M
YoY Change 2.17% 2.08%
Cash From Operating Activities $49.00M $58.00M
YoY Change -163.64% -1550.0%
INVESTING ACTIVITIES
Capital Expenditures $25.00M $26.00M
YoY Change -21.88% 23.81%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$25.00M -$26.00M
YoY Change -21.88% 18.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.000M
YoY Change 0.0%
Cash From Financing Activities -$10.00M -1.000M
YoY Change -108.2% 0.0%
NET CHANGE
Cash From Operating Activities $49.00M 58.00M
Cash From Investing Activities -$25.00M -26.00M
Cash From Financing Activities -$10.00M -1.000M
Net Change In Cash $9.000M 31.00M
YoY Change -47.06% -214.81%
FREE CASH FLOW
Cash From Operating Activities $49.00M $58.00M
Capital Expenditures $25.00M $26.00M
Free Cash Flow $24.00M $32.00M
YoY Change -122.02% -228.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
472617208 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
472617208 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
467092817 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
467092817 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
472617208 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
472617208 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
472617208 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
472617208 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
467092817 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
467092817 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2751000000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2748000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1437000000 usd
CY2024Q1 gbtg Cost Of Revenue Excluding Depreciation And Amortization
CostOfRevenueExcludingDepreciationAndAmortization
245000000 usd
CY2023Q1 gbtg Cost Of Revenue Excluding Depreciation And Amortization
CostOfRevenueExcludingDepreciationAndAmortization
242000000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
99000000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
103000000 usd
CY2024Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
108000000 usd
CY2023Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
101000000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
86000000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
72000000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
9000000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
23000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
46000000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
594000000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
587000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
16000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
34000000 usd
CY2024Q1 gbtg Fair Value Movement On Earnout Liabilities
FairValueMovementOnEarnoutLiabilities
18000000 usd
CY2023Q1 gbtg Fair Value Movement On Earnout Liabilities
FairValueMovementOnEarnoutLiabilities
3000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-19000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-27000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-25000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19000000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
3000000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
4000000 usd
CY2024Q1 gbtg Cost Of Revenue Excluding Depreciation And Amortization
CostOfRevenueExcludingDepreciationAndAmortization
245000000 usd
CY2023Q1 gbtg Cost Of Revenue Excluding Depreciation And Amortization
CostOfRevenueExcludingDepreciationAndAmortization
242000000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
99000000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
103000000 usd
CY2024Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
108000000 usd
CY2023Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
101000000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
86000000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
72000000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
9000000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
23000000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
47000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
46000000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
594000000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
587000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
16000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
33000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
34000000 usd
CY2024Q1 gbtg Fair Value Movement On Earnout Liabilities
FairValueMovementOnEarnoutLiabilities
18000000 usd
CY2023Q1 gbtg Fair Value Movement On Earnout Liabilities
FairValueMovementOnEarnoutLiabilities
3000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-19000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-27000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-25000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
461386280 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60376708 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
461386280 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
454825189 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-19000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
461386280 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60376708 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
461386280 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
454825189 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-19000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-27000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-24000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9000000 usd
CY2024Q1 gbtg Other Comprehensive Income Loss Cash Flow Hedge Gain Loss
OtherComprehensiveIncomeLossCashFlowHedgeGainLoss
5000000 usd
CY2023Q1 gbtg Other Comprehensive Income Loss Cash Flow Hedge Gain Loss
OtherComprehensiveIncomeLossCashFlowHedgeGainLoss
-11000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
2000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-21000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-31000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-19000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-27000000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
17000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
18000000 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
4000000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
6000000 usd
CY2024Q1 gbtg Fair Value Movements On Earnouts Derivative Liabilities
FairValueMovementsOnEarnoutsDerivativeLiabilities
18000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
95000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
163000000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
43000000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
47000000 usd
CY2024Q1 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-5000000 usd
CY2023Q1 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-8000000 usd
CY2024Q1 us-gaap Increase Decrease In Due To Affiliates Current
IncreaseDecreaseInDueToAffiliatesCurrent
5000000 usd
CY2023Q1 us-gaap Increase Decrease In Due To Affiliates Current
IncreaseDecreaseInDueToAffiliatesCurrent
37000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
144000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
63000000 usd
CY2024Q1 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
-7000000 usd
CY2023Q1 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
-7000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-77000000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
131000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1000000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-27000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-24000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9000000 usd
CY2024Q1 gbtg Other Comprehensive Income Loss Cash Flow Hedge Gain Loss
OtherComprehensiveIncomeLossCashFlowHedgeGainLoss
5000000 usd
CY2023Q1 gbtg Other Comprehensive Income Loss Cash Flow Hedge Gain Loss
OtherComprehensiveIncomeLossCashFlowHedgeGainLoss
-11000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
2000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
2000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-21000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-40000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-31000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-29000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-19000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-27000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
47000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46000000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
17000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
18000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
19000000 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
4000000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
6000000 usd
CY2024Q1 gbtg Fair Value Movements On Earnouts Derivative Liabilities
FairValueMovementsOnEarnoutsDerivativeLiabilities
18000000 usd
CY2023Q1 gbtg Fair Value Movements On Earnouts Derivative Liabilities
FairValueMovementsOnEarnoutsDerivativeLiabilities
3000000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
9000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
95000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
163000000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
43000000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
47000000 usd
CY2024Q1 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-5000000 usd
CY2023Q1 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-8000000 usd
CY2024Q1 us-gaap Increase Decrease In Due To Affiliates Current
IncreaseDecreaseInDueToAffiliatesCurrent
5000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
144000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
63000000 usd
CY2024Q1 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
-7000000 usd
CY2023Q1 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
-7000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-77000000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
131000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1000000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12000000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8000000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2000000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
122000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
489000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
316000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
498000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
333000000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-11000000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
34000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
33000000 usd
CY2024Q1 gbtg Non Cash Additions For Operating Lease Right Of Use Assets
NonCashAdditionsForOperatingLeaseRightOfUseAssets
6000000 usd
CY2023Q1 gbtg Non Cash Additions For Operating Lease Right Of Use Assets
NonCashAdditionsForOperatingLeaseRightOfUseAssets
5000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
475000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
475000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
476000000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
23000000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
13000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
498000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
489000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1212000000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
19000000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-19000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-21000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1174000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1371000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-27000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1352000000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures in the consolidated financial statements and accompanying notes. Estimates are used for, but not limited to, supplier revenue, allowance for credit losses, depreciable lives of property and equipment, acquisition purchase price allocations including valuation of acquired intangible assets and goodwill and contingent consideration, valuation of operating lease right-of-use (“ROU”) assets, impairment of goodwill, other intangible assets, long-lived assets, capitalized client incentives and investments in equity method investments, valuation allowances on deferred income taxes, valuation of pensions, interest rate swaps, earnout shares and contingent liabilities. Actual results could differ materially from those estimates.</span></div>
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8000000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2000000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
3000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
122000000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-5000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
489000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
316000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
498000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
333000000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-11000000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
34000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
33000000 usd
CY2024Q1 gbtg Non Cash Additions For Operating Lease Right Of Use Assets
NonCashAdditionsForOperatingLeaseRightOfUseAssets
6000000 usd
CY2023Q1 gbtg Non Cash Additions For Operating Lease Right Of Use Assets
NonCashAdditionsForOperatingLeaseRightOfUseAssets
5000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
475000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
475000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
476000000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
23000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
498000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
489000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1212000000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
19000000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-19000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-21000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1174000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1371000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
8000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-27000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1352000000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures in the consolidated financial statements and accompanying notes. Estimates are used for, but not limited to, supplier revenue, allowance for credit losses, depreciable lives of property and equipment, acquisition purchase price allocations including valuation of acquired intangible assets and goodwill and contingent consideration, valuation of operating lease right-of-use (“ROU”) assets, impairment of goodwill, other intangible assets, long-lived assets, capitalized client incentives and investments in equity method investments, valuation allowances on deferred income taxes, valuation of pensions, interest rate swaps, earnout shares and contingent liabilities. Actual results could differ materially from those estimates.</span></div>
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
610000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
578000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
610000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
578000000 usd
CY2024Q1 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
811000000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10000000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
30000000 usd
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
725000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
9000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19000000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
10000000 usd
CY2024Q1 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
811000000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10000000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
30000000 usd
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
725000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
9000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19000000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
10000000 usd
CY2024Q1 gbtg Prepaid Technology Expense Current
PrepaidTechnologyExpenseCurrent
53000000 usd
CY2023Q4 gbtg Prepaid Technology Expense Current
PrepaidTechnologyExpenseCurrent
36000000 usd
CY2024Q1 gbtg Prepaid Travel Expenses
PrepaidTravelExpenses
39000000 usd
CY2023Q4 gbtg Prepaid Travel Expenses
PrepaidTravelExpenses
13000000 usd
CY2024Q1 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
10000000 usd
CY2023Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
10000000 usd
CY2024Q1 us-gaap Prepaid Taxes
PrepaidTaxes
3000000 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
12000000 usd
CY2024Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
47000000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
45000000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
152000000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
116000000 usd
CY2024Q1 gbtg Prepaid Technology Expense Current
PrepaidTechnologyExpenseCurrent
53000000 usd
CY2023Q4 gbtg Prepaid Technology Expense Current
PrepaidTechnologyExpenseCurrent
36000000 usd
CY2024Q1 gbtg Prepaid Travel Expenses
PrepaidTravelExpenses
39000000 usd
CY2023Q4 gbtg Prepaid Travel Expenses
PrepaidTravelExpenses
13000000 usd
CY2024Q1 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
10000000 usd
CY2023Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
10000000 usd
CY2024Q1 us-gaap Prepaid Taxes
PrepaidTaxes
3000000 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
12000000 usd
CY2024Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
47000000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
45000000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
152000000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
116000000 usd
CY2024Q1 gbtg Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
206000000 usd
CY2023Q4 gbtg Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
160000000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
160000000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
184000000 usd
CY2024Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
73000000 usd
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
53000000 usd
CY2024Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
28000000 usd
CY2023Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
30000000 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
30000000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
19000000 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
12000000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8000000 usd
CY2024Q1 gbtg Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
526000000 usd
CY2023Q4 gbtg Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
466000000 usd
CY2024Q1 us-gaap Guaranty Liabilities
GuarantyLiabilities
27000000 usd
CY2024Q1 gbtg Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
206000000 usd
CY2023Q4 gbtg Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
160000000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
160000000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
184000000 usd
CY2024Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
73000000 usd
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
53000000 usd
CY2024Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
28000000 usd
CY2023Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
30000000 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
30000000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
19000000 usd
CY2024Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
9000000 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
12000000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8000000 usd
CY2024Q1 gbtg Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
526000000 usd
CY2023Q4 gbtg Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
466000000 usd
CY2024Q1 gbtg Cash Payments For Restructuring
CashPaymentsForRestructuring
11000000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
28000000 usd
CY2024Q1 gbtg Unconditional Guarantee Percentage Of Ebitda
UnconditionalGuaranteePercentageOfEbitda
0.70
CY2024Q1 us-gaap Purchase Obligation
PurchaseObligation
223000000 usd
CY2024Q1 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
94000000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
30000000 usd
CY2024Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
9000000 usd
CY2024Q1 gbtg Cash Payments For Restructuring
CashPaymentsForRestructuring
11000000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
28000000 usd
CY2024Q1 gbtg Unconditional Guarantee Percentage Of Ebitda
UnconditionalGuaranteePercentageOfEbitda
0.70
CY2024Q1 us-gaap Purchase Obligation
PurchaseObligation
223000000 usd
CY2024Q1 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
94000000 usd
CY2024Q1 us-gaap Guaranty Liabilities
GuarantyLiabilities
27000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
3.3378
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2388
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
3.3378
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2388
CY2024Q1 gbtg Fair Value Of Earn Out Share Liability
FairValueOfEarnOutShareLiability
59000000 usd
CY2024Q1 gbtg Gain Loss On Fair Value Change In Earnout Shares Liability
GainLossOnFairValueChangeInEarnoutSharesLiability
18000000 usd
CY2023Q1 gbtg Gain Loss On Fair Value Change In Earnout Shares Liability
GainLossOnFairValueChangeInEarnoutSharesLiability
3000000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12000000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
14000000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
14000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
0 usd
CY2024Q1 gbtg Earn Out Shares Shares Subject To Forfeiture If Threshold Stock Price Not Achieved
EarnOutSharesSharesSubjectToForfeitureIfThresholdStockPriceNotAchieved
23000000 shares
CY2024Q1 gbtg Fair Value Of Earn Out Share Liability
FairValueOfEarnOutShareLiability
59000000 usd
CY2024Q1 gbtg Gain Loss On Fair Value Change In Earnout Shares Liability
GainLossOnFairValueChangeInEarnoutSharesLiability
18000000 usd
CY2023Q1 gbtg Gain Loss On Fair Value Change In Earnout Shares Liability
GainLossOnFairValueChangeInEarnoutSharesLiability
3000000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
14000000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
14000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-25000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-19000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-27000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
461386280 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60376708 shares
CY2024Q1 gbtg Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock
0 shares
CY2023Q1 gbtg Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock
394448481 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
461386280 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
454825189 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-25000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-19000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-27000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
461386280 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60376708 shares
CY2024Q1 gbtg Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock
0 shares
CY2023Q1 gbtg Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock
394448481 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
461386280 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
454825189 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
20000000 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
5000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
8000000 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
5000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
8000000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 gbtg Cost Of Revenue Excluding Depreciation And Amortization
CostOfRevenueExcludingDepreciationAndAmortization
245000000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
99000000 usd
CY2024Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
108000000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
86000000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001820872-24-000024-index-headers.html Edgar Link pending
0001820872-24-000024-index.html Edgar Link pending
0001820872-24-000024.txt Edgar Link pending
0001820872-24-000024-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gbtg-20240331.htm Edgar Link pending
gbtg-20240331.xsd Edgar Link pending
gbtg-20240331xexx311.htm Edgar Link pending
gbtg-20240331xexx312.htm Edgar Link pending
gbtg-20240331xexx321.htm Edgar Link pending
gbtg-20240331xexx322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gbtg-20240331_cal.xml Edgar Link unprocessable
gbtg-20240331_def.xml Edgar Link unprocessable
gbtg-20240331_lab.xml Edgar Link unprocessable
gbtg-20240331_pre.xml Edgar Link unprocessable
gbtg-20240331_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending